All Substitutes

Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
Tfct NIB 5mg Tablet_202195 (1)
Tfct NIB 5mg Tablet_202195 (2)
Tfct NIB 5mg Tablet_202195 (1)
15% Off

Tfct NIB 5mg Tablet

Prescription Required

Salt Composition : Tofacitinib

Manufacturer : IPCA LABORATORIES LTD

Origin of Medicine : India

MRP: ₹483.7
Price : ₹411
You Save : ₹73 (15%)

10 Tablet(s) In A Strip

Pincode
Delivery By -

Introduction to Tfct Nib 5mg Tablet

TFCT NIB 5mg tablet contains the active substance Tofacitinib. It is a disease-modifying anti-rheumatoid drug (DMARDs) that belongs to the class immunomodulators. It is used alone or with other medications to treat rheumatoid arthritis (A condition in which the body attacks its joints, causing pain, swelling, and loss of function) in adults who are unable to take or do not respond to other medications. It is also used to treat psoriatic arthritis (A condition that causes joint pain and swelling, and scales on the skin). It is also indicated for treating adult patients with moderately to severely active ulcerative colitis.  

Other uses of TFCT NIB 5mg tablet include ankylosing spondylitis (inflammatory disease of the spine). It is also used to treat active polyarticular juvenile idiopathic arthritis, a long-term disease mainly causes pain and swelling of your joints in patients 2 years of age and older. The medicine works by decreasing the activity of the immune system. Inform your physician if you have a severe blood infection, active tuberculosis, and liver problems. Notify your doctor if you ever had or have a hepatitis B infection because this medicine could cause the hepatitis B to become active again.   

Do not take TFCT NIB 5mg tablet if you are allergic to tofacitinib or any other ingredients of this medicine. Inform your healthcare professional if you have any symptoms of an infection, such as fever, sweating, chills, muscle aches, cough, shortness of breath, weight loss, skin sores, difficulty or pain when swallowing, diarrhea, or stomach pain. Before initiating the treatment, inform your physician if you have kidney, heart, lung, or liver problems, a history of tuberculosis, high blood pressure, or high cholesterol, and also if you are a current or past smoker.

Uses of Tfct Nib 5mg Tablet

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Ulcerative colitis
  • Polyarticular juvenile idiopathic arthritis
  • Juvenile psoriatic arthritis

Therapeutic Effects of Tfct Nib 5mg Tablet

TFCT NIB 5mg tablet is a disease-modifying anti-rheumatic drug (DMARD) in the category of Janus Kinase Inhibitors. Janus kinase is a type of enzyme (tyrosine kinase)  involved in the signaling of cytokine receptors. It works by inhibiting Janus kinases and interferes with the transcription of genes involved in cell growth and differentiation.

Interaction of Tfct Nib 5mg Tablet with other drugs

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications may interact with the effects of TFCT NIB 5mg tablet and reduce its effectiveness by causing undesirable side effects.

More Information about Tfct Nib 5mg Tablet

  • Store tofacitinb at room temperature (20°C to 25°C)
  • keep the tablet away from the reach of children and pets.
  • If you forgot to take a dose, take it as soon as you remember. However, if it is nearly time for the next dose, skip the missed dose.
  • Do not take a double dose to make up a forgotten dose.

How to consume Tfct Nib 5mg Tablet

Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Take the tablets as prescribed by your doctor. Do not break, crush, or chew the tablets. Swallow the tablet whole with a glass of water. Take the tablet with or without food.

Safety Advices for Tfct Nib 5mg Tablet

Image Not Available  

Pregnancy

  

TFCT NIB 5mg tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for at least 4 weeks after your last dose is necessary.  

Image Not Available  

Breast Feeding

  

Breastfeeding is not recommended in patients taking TFCT NIB 5mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. 

Image Not Available  

Lungs

  

It is unknown whether TFCT NIB 5mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.

Image Not Available  

Liver

  

TFCT NIB  5mg tablet is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in severe liver failure. Inform your physician if you have liver problems before initiating the therapy.  

Image Not Available  

Alcohol

  

It is unknown whether it is safe to consume alcohol when taking TFCT NIB 5mg   tablet. Consult your doctor for more advice.

Image Not Available  

Driving

  

The drug has no or limited effect on your ability to drive or operate heavy machines. If you face any difficulties, consult your doctor for more advice.

Side Effects of Tfct Nib 5mg Tablet

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. 

 Common

  • Increased cholesterol levels
  • Headache
  • Painful urination
  • Inflammation of the nose
  • Cough
  • Shortness of breath
  • Diarrhea
  • Skin rashes

Serious 

  • Lung cancer
  • White blood cell cancer
  • Heart attack
  • Fever and chills
  • Blood in the stool
  • Stomach pain or abdominal pain
  • Skin blisters

Word of Advice

This medicine may interfere with vaccines, inform your physician about your vaccination history. This medicine may impair fertility; talk to your doctor before taking this medicine. Your doctor will regularly do lab tests to check whether the medicine is working. Do not breastfeed during the treatment with this medicine and for at least 36 hours after your last dose. This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury.

FAQs

Q 1. What are the cautions of TFCT NIB 5mg tablet?

Tell your doctor immediately if you start to have swelling of your face, lips, tongue, throat, arms, or legs or if you are having trouble swallowing or breathing. TFCT NIB 5mg tablet can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection.

Q 2. Does TFCT NIB 5mg tablet cause high cholesterol?

Increased cholesterol levels are one of the side effects of TFCT NIB 5mg tablet, your doctor may take regular blood tests to check for serious side effects.

Q 3. Can TFCT NIB 5mg tablet cause depression?

No, TFCT NIB 5mg tablet does not cause depression. However, many people who have autoimmune conditions also have symptoms of depression. If you're having symptoms of depression, see your doctor right away.

Q 4. Does TFCT NIB 5mg tablet cause blood clots?

TFCT NIB 5mg tablet is a long-term treatment. Most people who benefit from this treatment will notice an improvement in the first 12 weeks of starting treatment.

Fact Box of Tfct Nib 5mg Tablet

Molecule name: Tofacitinib 

Therapeutic class: Antirheumatoid

Pharmacological class: Tyrosine kinase inhibitor

Indications: 

1. Rheumatoid arthritis

2. Psoriatic arthritis

3. Ankylosing spondylitis

4. Ulcerative colitis

5. Polyarticular juvenile idiopathic arthritis 

6. Juvenile psoriatic arthritis 

References

  1. XELJANZ 5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [cited 2023 Mar 25]. Available from: https://www.medicines.org.uk/emc/product/2500/smpc
  2. HIGHLIGHTS OF PRESCRIBING INFORMATION - Tofacitinib. [revised on 2018] [cited 2023 Mar 25]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203214s018lbl.pdf
  3. ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - Tofacitinib. [cited 2023 Mar 25]. Available from: https://www.ema.europa.eu/en/documents/product-information/xeljanz-epar-product-information_en.pdf

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.